This briefing is sourced from an SEC EDGAR filing published on June 22, 2026. The specific form type is not identified in the source materials. The transaction currently holds pending-regulatory status, indicating that regulatory approval or clearance remains outstanding and the deal has not yet closed.
Morgan Stanley has been retained as the lead financial advisor to QXO in this transaction. According to the bank's opinion letter disclosure, Morgan Stanley and its affiliates have received aggregate fees totaling between 85 million and 110 million dollars over the two-year period preceding the delivery of Morgan Stanley's written opinion for financial advisory and financing services provided to QXO. This fee range encompasses both the advisory services related to the current transaction and other prior engagements with the acquirer.
No legal advisors have been identified in the source materials provided for this transaction.
The specific deal structure, consideration composition, form of consideration (cash, stock, or mixed), and any other material transaction terms have not been disclosed in the available documentation. Similarly, the identity of the target company or any details specific to the target's business, size, or assets remain absent from the source materials.
Notably, no expected closing or completion date has been disclosed. The consideration amount is entirely undisclosed. The target company's name and sector are not identified. The specific nature of the regulatory approvals or conditions required for closing are not detailed. The roles and identities of any other financial or legal advisors to either party, if any exist, have not been extracted from the available sources. The structure of any transaction consideration, including whether it will be all-cash, all-stock, or some combination, remains completely unspecified in the materials reviewed.